Logo image of CSGP

COSTAR GROUP INC (CSGP) Stock Fundamental Analysis

USA - NASDAQ:CSGP - US22160N1090 - Common Stock

88.13 USD
-0.84 (-0.94%)
Last: 9/16/2025, 5:20:00 PM
88.03 USD
-0.1 (-0.11%)
After Hours: 9/16/2025, 5:20:00 PM
Fundamental Rating

5

Taking everything into account, CSGP scores 5 out of 10 in our fundamental rating. CSGP was compared to 63 industry peers in the Real Estate Management & Development industry. CSGP has an average financial health and profitability rating. CSGP is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CSGP was profitable.
CSGP had a positive operating cash flow in the past year.
In the past 5 years CSGP has always been profitable.
In the past 5 years CSGP always reported a positive cash flow from operatings.
CSGP Yearly Net Income VS EBIT VS OCF VS FCFCSGP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

CSGP has a Return On Assets of 0.99%. This is in the better half of the industry: CSGP outperforms 65.08% of its industry peers.
CSGP has a Return On Equity of 1.21%. This is in the better half of the industry: CSGP outperforms 63.49% of its industry peers.
Industry RankSector Rank
ROA 0.99%
ROE 1.21%
ROIC N/A
ROA(3y)3.37%
ROA(5y)3.48%
ROE(3y)4.11%
ROE(5y)4.33%
ROIC(3y)N/A
ROIC(5y)N/A
CSGP Yearly ROA, ROE, ROICCSGP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8

1.3 Margins

Looking at the Profit Margin, with a value of 3.57%, CSGP is in the better half of the industry, outperforming 73.02% of the companies in the same industry.
CSGP's Profit Margin has declined in the last couple of years.
In the last couple of years the Operating Margin of CSGP has declined.
Looking at the Gross Margin, with a value of 79.33%, CSGP belongs to the top of the industry, outperforming 92.06% of the companies in the same industry.
CSGP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 3.57%
GM 79.33%
OM growth 3Y-80.23%
OM growth 5Y-63.35%
PM growth 3Y-30.42%
PM growth 5Y-25.78%
GM growth 3Y-0.84%
GM growth 5Y0.06%
CSGP Yearly Profit, Operating, Gross MarginsCSGP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

6

2. Health

2.1 Basic Checks

CSGP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CSGP has been increased compared to 1 year ago.
The number of shares outstanding for CSGP has been increased compared to 5 years ago.
The debt/assets ratio for CSGP has been reduced compared to a year ago.
CSGP Yearly Shares OutstandingCSGP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
CSGP Yearly Total Debt VS Total AssetsCSGP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 12.86 indicates that CSGP is not in any danger for bankruptcy at the moment.
CSGP has a better Altman-Z score (12.86) than 87.30% of its industry peers.
CSGP has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
CSGP's Debt to Equity ratio of 0.12 is fine compared to the rest of the industry. CSGP outperforms 76.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z 12.86
ROIC/WACCN/A
WACC9.25%
CSGP Yearly LT Debt VS Equity VS FCFCSGP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

CSGP has a Current Ratio of 5.83. This indicates that CSGP is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 5.83, CSGP belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
A Quick Ratio of 5.83 indicates that CSGP has no problem at all paying its short term obligations.
CSGP's Quick ratio of 5.83 is amongst the best of the industry. CSGP outperforms 92.06% of its industry peers.
Industry RankSector Rank
Current Ratio 5.83
Quick Ratio 5.83
CSGP Yearly Current Assets VS Current LiabilitesCSGP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

6

3. Growth

3.1 Past

The earnings per share for CSGP have decreased by -5.68% in the last year.
The Earnings Per Share has been decreasing by -6.71% on average over the past years.
The Revenue has grown by 12.18% in the past year. This is quite good.
Measured over the past years, CSGP shows a quite strong growth in Revenue. The Revenue has been growing by 14.35% on average per year.
EPS 1Y (TTM)-5.68%
EPS 3Y-14.08%
EPS 5Y-6.71%
EPS Q2Q%13.33%
Revenue 1Y (TTM)12.18%
Revenue growth 3Y12.07%
Revenue growth 5Y14.35%
Sales Q2Q%15.27%

3.2 Future

Based on estimates for the next years, CSGP will show a very strong growth in Earnings Per Share. The EPS will grow by 33.96% on average per year.
CSGP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.54% yearly.
EPS Next Y14.17%
EPS Next 2Y38.19%
EPS Next 3Y41.22%
EPS Next 5Y33.96%
Revenue Next Year15.79%
Revenue Next 2Y14.89%
Revenue Next 3Y14.51%
Revenue Next 5Y12.54%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CSGP Yearly Revenue VS EstimatesCSGP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
CSGP Yearly EPS VS EstimatesCSGP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 106.18 indicates a quite expensive valuation of CSGP.
60.32% of the companies in the same industry are more expensive than CSGP, based on the Price/Earnings ratio.
CSGP's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.20.
With a Price/Forward Earnings ratio of 64.10, CSGP can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CSGP indicates a somewhat cheap valuation: CSGP is cheaper than 68.25% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of CSGP to the average of the S&P500 Index (22.71), we can say CSGP is valued expensively.
Industry RankSector Rank
PE 106.18
Fwd PE 64.1
CSGP Price Earnings VS Forward Price EarningsCSGP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

CSGP's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 190.03
CSGP Per share dataCSGP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CSGP does not grow enough to justify the current Price/Earnings ratio.
CSGP's earnings are expected to grow with 41.22% in the coming years. This may justify a more expensive valuation.
PEG (NY)7.49
PEG (5Y)N/A
EPS Next 2Y38.19%
EPS Next 3Y41.22%

0

5. Dividend

5.1 Amount

CSGP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

COSTAR GROUP INC

NASDAQ:CSGP (9/16/2025, 5:20:00 PM)

After market: 88.03 -0.1 (-0.11%)

88.13

-0.84 (-0.94%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)07-22 2025-07-22/amc
Earnings (Next)10-20 2025-10-20/amc
Inst Owners105.81%
Inst Owner Change-0.75%
Ins Owners0.69%
Ins Owner Change-1.25%
Market Cap37.34B
Analysts80
Price Target98.84 (12.15%)
Short Float %3.98%
Short Ratio6.12
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)56.04%
Min EPS beat(2)21.03%
Max EPS beat(2)91.05%
EPS beat(4)4
Avg EPS beat(4)39.69%
Min EPS beat(4)13.92%
Max EPS beat(4)91.05%
EPS beat(8)7
Avg EPS beat(8)33.64%
EPS beat(12)11
Avg EPS beat(12)25.84%
EPS beat(16)15
Avg EPS beat(16)23.56%
Revenue beat(2)0
Avg Revenue beat(2)-1.23%
Min Revenue beat(2)-1.67%
Max Revenue beat(2)-0.8%
Revenue beat(4)0
Avg Revenue beat(4)-1.5%
Min Revenue beat(4)-2.45%
Max Revenue beat(4)-0.8%
Revenue beat(8)0
Avg Revenue beat(8)-1.51%
Revenue beat(12)0
Avg Revenue beat(12)-1.63%
Revenue beat(16)0
Avg Revenue beat(16)-1.54%
PT rev (1m)1.13%
PT rev (3m)11.06%
EPS NQ rev (1m)-2.28%
EPS NQ rev (3m)-34.74%
EPS NY rev (1m)0.95%
EPS NY rev (3m)-5.19%
Revenue NQ rev (1m)0.5%
Revenue NQ rev (3m)6.56%
Revenue NY rev (1m)0.59%
Revenue NY rev (3m)0.94%
Valuation
Industry RankSector Rank
PE 106.18
Fwd PE 64.1
P/S 12.81
P/FCF N/A
P/OCF 94.62
P/B 4.34
P/tB 9.34
EV/EBITDA 190.03
EPS(TTM)0.83
EY0.94%
EPS(NY)1.37
Fwd EY1.56%
FCF(TTM)0
FCFYN/A
OCF(TTM)0.93
OCFY1.06%
SpS6.88
BVpS20.3
TBVpS9.43
PEG (NY)7.49
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.99%
ROE 1.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 3.57%
GM 79.33%
FCFM N/A
ROA(3y)3.37%
ROA(5y)3.48%
ROE(3y)4.11%
ROE(5y)4.33%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)3%
ROCE(5y)3.93%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-80.23%
OM growth 5Y-63.35%
PM growth 3Y-30.42%
PM growth 5Y-25.78%
GM growth 3Y-0.84%
GM growth 5Y0.06%
F-Score5
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA 5.52
Cap/Depr 211.14%
Cap/Sales 13.59%
Interest Coverage N/A
Cash Conversion 217.65%
Profit Quality N/A
Current Ratio 5.83
Quick Ratio 5.83
Altman-Z 12.86
F-Score5
WACC9.25%
ROIC/WACCN/A
Cap/Depr(3y)211.68%
Cap/Depr(5y)162.35%
Cap/Sales(3y)11.14%
Cap/Sales(5y)9.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.68%
EPS 3Y-14.08%
EPS 5Y-6.71%
EPS Q2Q%13.33%
EPS Next Y14.17%
EPS Next 2Y38.19%
EPS Next 3Y41.22%
EPS Next 5Y33.96%
Revenue 1Y (TTM)12.18%
Revenue growth 3Y12.07%
Revenue growth 5Y14.35%
Sales Q2Q%15.27%
Revenue Next Year15.79%
Revenue Next 2Y14.89%
Revenue Next 3Y14.51%
Revenue Next 5Y12.54%
EBIT growth 1Y-108.74%
EBIT growth 3Y-77.85%
EBIT growth 5Y-58.09%
EBIT Next Year3050.45%
EBIT Next 3Y337.87%
EBIT Next 5Y157.07%
FCF growth 1Y-100.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-30.15%
OCF growth 3Y-5.8%
OCF growth 5Y-3.03%